Apellis Pharmaceuticals Inc (APLS)
27.40
-0.09
(-0.33%)
USD |
NASDAQ |
Nov 21, 11:58
Apellis Pharmaceuticals Price: 27.40 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 28.78 | 28.98 | 27.38 | 27.49 | 3.315M |
| Nov 19, 2024 | 28.50 | 30.80 | 27.89 | 28.99 | 11.27M |
| Nov 18, 2024 | 26.45 | 26.66 | 25.76 | 26.18 | 7.667M |
| Nov 15, 2024 | 28.05 | 28.05 | 26.02 | 26.27 | 5.505M |
| Nov 14, 2024 | 28.44 | 28.87 | 27.81 | 28.06 | 5.514M |
| Nov 13, 2024 | 29.40 | 29.94 | 28.23 | 28.25 | 1.595M |
| Nov 12, 2024 | 29.25 | 29.60 | 28.79 | 29.26 | 1.172M |
| Nov 11, 2024 | 30.11 | 30.46 | 29.56 | 29.58 | 2.139M |
| Nov 08, 2024 | 28.68 | 30.14 | 28.51 | 29.98 | 4.756M |
| Nov 07, 2024 | 28.67 | 29.05 | 27.73 | 28.74 | 2.098M |
| Nov 06, 2024 | 29.93 | 29.99 | 27.27 | 28.83 | 3.843M |
| Nov 05, 2024 | 25.40 | 28.33 | 24.34 | 28.08 | 10.60M |
| Nov 04, 2024 | 27.58 | 30.12 | 27.47 | 28.56 | 9.305M |
| Nov 01, 2024 | 27.31 | 28.10 | 27.11 | 27.98 | 3.251M |
| Oct 31, 2024 | 27.55 | 28.17 | 27.21 | 27.26 | 1.665M |
| Oct 30, 2024 | 26.86 | 28.06 | 26.80 | 27.71 | 1.655M |
| Oct 29, 2024 | 27.42 | 28.09 | 26.95 | 27.41 | 1.491M |
| Oct 28, 2024 | 27.50 | 27.80 | 26.67 | 27.34 | 2.253M |
| Oct 25, 2024 | 27.18 | 27.80 | 26.67 | 26.68 | 1.123M |
| Oct 24, 2024 | 26.82 | 28.22 | 26.80 | 27.58 | 1.523M |
| Oct 23, 2024 | 27.60 | 27.65 | 26.77 | 26.98 | 2.980M |
| Oct 22, 2024 | 26.62 | 28.12 | 26.48 | 27.60 | 5.081M |
| Oct 21, 2024 | 27.93 | 28.00 | 26.53 | 26.88 | 3.298M |
| Oct 18, 2024 | 27.90 | 28.34 | 27.75 | 28.00 | 1.508M |
| Oct 17, 2024 | 27.92 | 28.28 | 27.46 | 27.92 | 1.501M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
17.91
Minimum
Mar 17 2020
93.31
Maximum
Jun 13 2023
47.34
Average
45.16
Median
Apr 26 2021
Price Benchmarks
| Biomarin Pharmaceutical Inc | 62.57 |
| Ionis Pharmaceuticals Inc | 35.02 |
| EyePoint Pharmaceuticals Inc | 8.49 |
| Cassava Sciences Inc | 28.14 |
| Macrogenics Inc | 3.265 |
Price Related Metrics
| PS Ratio | 4.715 |
| Price to Book Value | 14.37 |
| Earnings Yield | -7.41% |
| Market Cap | 3.408B |